(MENAFN- GlobeNewsWire - Nasdaq) Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license ...

SAN MATEO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...

Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis ...

While multiple internal strife, a Taliban offensive at the Afghan border, and maintaining harmony with the powerful Pakistan Army are adding to Islamabad’s woes, the miserable economic condition has ...

And experts now say that the endless, expensive 10-step routines promoted on social media may be doing more harm than good. 'Acne is one of the most common skin concern, whatever age you are, but it ...

Non-profit entities that suffered damage or other issues related to severe weather in June are now eligible for low-interest federal disaster loans. The Small Business Administration says private ...

Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.

Thanks For Watching Subscribe to become a part of #HealthApta SUBSCRIBE for awesome videos every day!: Like, Comment, Share and Enjoy the videos. Colorado school shooting came hours after parents ...

I could've avoided some deep scars (and a serious self-confidence knock) if I had trusted the dermatologist who initially prescribed spironolactone for my cystic acne. But instead of planting that ...